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7METHODOLOGY ARTICLE Open Access8p23 beta-defensin copy number determination
by single-locus pseudogene-based paralog ratio
tests risk bias due to low-frequency sequence
variations
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Background: The copy number variation (CNV) in beta-defensin genes (DEFB) on human chromosome 8p23 has
been proposed to contribute to the phenotypic differences in inflammatory diseases. However, determination of
exact DEFB CN is a major challenge in association studies. Quantitative real-time PCR (qPCR), paralog ratio tests
(PRT) and multiplex ligation-dependent probe amplification (MLPA) have been extensively used to determine DEFB
CN in different laboratories, but inter-method inconsistencies were observed frequently. In this study we asked
which one is superior among the three methods for DEFB CN determination.
Results: We developed a clustering approach for MLPA and PRT to statistically correlate data from a single
experiment. Then we compared qPCR, a newly designed PRT and MLPA for DEFB CN determination in 285 DNA
samples. We found MLPA had the best convergence and clustering results of the raw data and the highest call rate.
In addition, the concordance rates between MLPA or PRT and qPCR (32.12% and 37.99%, respectively) were
unacceptably low with underestimated CN by qPCR. Concordance rate between MLPA and PRT (90.52%) was high
but PRT systematically underestimated CN by one in a subset of samples. In these samples a sequence variant
which caused complete PCR dropout of the respective DEFB cluster copies was found in one primer binding site of
one of the targeted paralogous pseudogenes.
Conclusion: MLPA is superior to PRT and even more to qPCR for DEFB CN determination. Although the applied
PRT provides in most cases reliable results, such a test is particularly sensitive to low-frequency sequence variations
preferably accumulating in loci like pseudogenes which are most likely not under selective pressure. In the light of
the superior performance of multiplex assays, the drawbacks of such single PRTs could be overcome by combining
more test markers.
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Copy number variation (CNV) is very common in human
genome [1,2]. Among the many genes affected by CNV,
the beta-defensin genes (DEFBs) which are located in
chromosome 8p23.1 have been well characterized to be
extensively variable in populations [3-6]. These DEFBs
form a cluster, and 2 to 12 copies of DEFB cluster were
reported in a diploid genome [4,7]. There is a correlation
between copy number (CN) and DEFB4 expression at
mRNA level in a variety of cells [4,8-10] i.e. CN are prone
to shape phenotypes.
Beta-defensins are a group of cationic antimicrobial pep-
tides. They are mainly expressed in skin and mucus and
can be strongly induced after infection, so beta-defensins
are considered to contribute to the first line of defense
against invading pathogens [11]. In addition, beta-defensins
are able to modulate the immune response [12].
Given the functions of beta-defensins in the immune
system, researchers have investigated the association be-
tween DEFB CN and inflammatory diseases. Increased
DEFB CN was reported to be associated with the risk of
psoriasis [13,14]. Fellerman et al. found an association
between low DEFB CN and Crohn’s disease of colon [8].
On the contrary, Bentley et al. reported an association
between high DEFB CN and Crohn’s disease [15]. How-
ever, none of the associations can be replicated in a re-
cent study by Aldhous et al. [16] which is in main part
due to uncertainty in CN determination. The discrepan-
cies raised the necessity to find reliable methods for
DEFB CN determination.
So far, it is still a challenge to determine the exact DEFB
CN. Three PCR based methods, real-time PCR (qPCR)
[8,15,17,18], paralog ratio tests (PRT) [14,16,19-21] and
multiplex ligation-dependent probe amplification (MLPA)
[7,20,22,23] have being extensively used to determine
DEFB CN. qPCR was advantageous due to universal ap-
plicability and relative simplicity, but the reliability of this
method was questioned [16,22,24]. PRT was designed to
avoid the PCR heterogeneity between reference and target
genes by using one pair of primers targeting paralogs of a
pseudogene [20]. Combined with simplicity and high
throughput, PRT is becoming more and more popular,
and different designs were used [16,20,24,25]. MLPA has
the capacity to interrogate a great deal of locus including
target and reference in a single reaction [7,26]. Neverthe-
less, it is relatively expensive and time-consuming and
requires larger amounts of sample DNA. When the CNs
determined by these three methods were compared dir-
ectly in the same samples, inter-method inconsistencies
were observed frequently [7,22,24]. Therefore, in this
study we asked which one is superior among the three
methods for DEFB CN determination. To answer this
question, we compared qPCR, PRT and MLPA for DEFB
CN determination in 285 DNA samples. Furthermore weinvestigated the reason for inconsistent CN determination
by PRT compared to by MLPA.
Results
Integer CN assignment and call rate
In order to compare the performance of qPCR, PRT4 and
MLPA, DEFB CNs were determined in DNA from blood
of 285 healthy Europeans (see Additional file 1). To evalu-
ate the distribution of the raw data of each method indi-
vidually, the raw CNs of all samples from qPCR (with the
calibrator included in each run), the raw CNs of a typical
96-well plate from PRT4 and the relative locus dose of a
typical batch from MLPA were plotted in an ascending
order (Figure 1). The distributions of the raw CNs of the
other PRT4 plates and the relative locus dose of the other
MLPA batches are shown in Additional file 2 and
Additional file 3, respectively. In qPCR, the raw CNs are
distributed continuously, and no clustering around integer
CNs was observed. In contrast, for MLPA the relative
locus dose increases stepwise and clear intervals between
neighboring CN clusters are visible as shown in the plot
as “gaps”. For PRT4, a plot between these two extremes
was obtained.
For qPCR, raw CN were rounded to the nearest inte-
ger. For PRT4 and MLPA, a clustering algorithm was ap-
plied creating likelihood values for integer assignments.
In Figure 2, the clustering results of a typical 96-well
plate/batch were shown for PRT4 and MLPA, respect-
ively. The distribution of raw data around the cluster
centers is broader for PRT4 than for MLPA. Accordingly,
the likelihood value of PRT4 was significantly lower than
that of MLPA (Figure 3). Moreover, 9.8% of the samples
did not pass the threshold of likelihood in PRT4. In con-
trast, all but two samples passed in MLPA.
The qPCR and PRT4 assays were performed twice and
samples were considered if the results from the dupli-
cates were consistent. The call rate of MLPA was with
99.3% the highest among three methods in contrast to
qPCR (96.8%) and PRT4 (82.1%). Among uncalled sam-
ples in PRT4, 78.4% showed an MPLA-CN ≥ 5.
Inter-method concordance and discordance
Concordance and discordance between methods were
evaluated by pairwise comparison of CNs (Table 1). For
visualization of the inter-method difference, Bland-Altman
plots were applied (Figure 4). The concordance rates among
three method pairs were significantly different (P < 0.0001;
Chi-square test). The concordance rate between MLPA
and PRT4 (90.5%) was the highest. Accordingly, the range
of limit of agreement between MLPA and PRT4 (−0.48 to
0.67) is the smallest. In comparison to MLPA, qPCR
underestimated the CN (on average by 0.78), with greater
underestimation at higher CN. When PRT4 and qPCR
CNs were compared, we observed a very similar trend.
Figure 1 Scatter plots of raw data of the three methods. Raw
data were plotted in ascending order. (A) qPCR - raw CNs of all
samples were included. (B) PRT4 - raw CNs of samples in a typical
96-well plate were included. (C) MLPA - the relative locus dose
(right axis) of samples in a typical batch were included.
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cases (9.5%) the PRT underestimated the CN by 1. In
addition, a linear trend between CN and the fraction
of underestimated samples is very likely (P = 0.023,
Chi-square test for trend, Figure 5).
Genomic variation in a PRT4 primer binding site
As the discordance between MLPA and PRT4 could be
confirmed for selected samples repeatedly, we speculated
that PRT4 may systematically miss a particular target
allele in the DEFB region. Therefore, 10 samples dis-
cordant between MLPA and PRT4 were selected forvariation screening in the PRT4 primer binding sites by
sequencing. A C > T paralogous sequence variation (PSV,
chr8: 7277574, rs187261177) was found in the forward
primer binding site in 9 samples (Figure 6, Table 2). The
variant was not found among 65 clones obtained from the
genomic DNA pool which indicates a significant differ-
ence in the rs187261177 minor allele frequency (MAF)
among random samples and those 10 selected for their
MLPA/PRT4 discordance (P < 0.001, Fisher’s exact test).
To test whether the T allele was missed in PRT4, 2 clones
containing T allele amplicons from RC017 and RC147 and
2 clones containing C allele amplicons from RC017 and
RC147 identified by sequencing were used as test sam-
ples and control samples, respectively. The result indi-
cates that the T allele cannot be amplified by the PRT4
PCR (Figure 7), even in the artificial condition of an ex-
tremely low complexity and high-copy template.
CN distributions from three methods
Compared to the CN distribution obtained by MLPA,
the qPCR and PRT4 patterns are shifted towards low
CNs (Figure 8). Although the medians from the three
methods were all 4, they were statistically different
(P < 0.0001; Kruskal-Wallis test). Multiple comparisons
qPCR vs PRT4, qPCR vs MLPA and PRT4 vs MLPA also
showed significant differences (P < 0.001, P < 0.001 and
P < 0.05, respectively; post-hoc Dunn’s test).
Discussion
In the present study, we compared the call rates and
concordance of qPCR, PRT4 and MLPA for the DEFB CN
determination. We herewith extended a previous study
[22] where qPCR and MLPA were explored on 42 cell line
and 38 blood derived samples. In the present study, we
included a PRT as respective approaches which are com-
bining simplicity and high throughput and becoming
popular in the field [16,20,24]. Moreover, we extended the
test sample considerably to 285 DNAs isolated from blood
of healthy donors with European ancestry. Furthermore, a
clustering algorithm was used to infer the integer CN
from raw data in PRT4 and MLPA with a threshold of
confidence.
In respect to raw data, we found the best convergence
for MLPA. “Gaps” of locus dose between neighboring clus-
ters provide discriminatory power to the method resulting
in higher confidence for the CN estimation compared to
PRT4. Nearly no clustering of raw data at all was observed
for qPCR, which confirmed the findings of previous re-
ports [16,22,24]. It results in frequent typing errors and
serious shortcomings of this method. qPCR systematically
underestimated in particular higher CNs, which confirmed
our results in a previous report [22].
For this study, we developed a clustering algorithm
with confidence of determination to infer CN from raw
Figure 2 Integer CN assignment using a clustering algorithm for (A) PRT4 and (B) MLPA. Results of a typical 96-well plate/batch are shown
for PRT4 and MLPA, respectively. The dark blue lines indicate the means of the clusters with their values above and assigned integer CNs in brackets.
The light blue lines indicate the primary cluster center obtained from reference samples. Circles with the same color represent one cluster. The dashed
line indicates the threshold of likelihood below which samples were discarded.
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Figure 3 Likelihood values of PRT4 and MLPA shown as box
plots. Box represents the region between the first and the third
quartile (i.e. the central 50 % of the data). The horizontal line in the
box represents the median. The end of the vertical line marks the
smallest likelihood value located less than 1.5 times the interquartile
distance from the first quartile. Other observations may be deemed
outliers and are shown as dots. ***P < 0.001 in a Mann–Whitney test.
Figure 4 Bland-Altman plots for inter-method comparisons of
(A) PRT4-qPCR (B) MLPA-qPCR and (C) MLPA-PRT4. The plots
show the difference between the methods against their mean.
The dots were offset to allow individual measurements to be
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rounding to the nearest integer [5,17], linear regression
by integrating reference samples [18,20,24] and Gaussian
mixture modeling [16] were used. Signal saturation as
the CN increases was reported in PPRT and MLPA [7].
So directly rounding the raw data to the nearest integer
may underestimate the CN, and linear regression may
overestimate or underestimate the CN. Gaussian mixture
modeling was well established for CN calling from large
data sets. For small data sets, however, CN calls will be
biased particularly for high CNs due to the low data
amount in the clusters to form Gaussian curves. In ex-
treme cases of no data in one or even more clusters, the
Gaussian curves for adjacent clusters will be remarkably
affected and CNs will be misestimated eventually. In theTable 1 Concordant and discordant results between
methods
ΔCN −1 0 +1 +2
PRT4 - qPCR 6 (2.6%) 87 (38.0%) 125 (54.6%) 11 (4.8%)
MLPA - qPCR 0 88 (32.1%) 158 (57.7%) 28 (10.2%)
MLPA - PRT4 0 210 (90.5%) 22 (9.5%) 0
distinguished. The solid line represents the mean of all ΔCNs and
the dashed line is 1.96 times the standard deviation (limit of
agreement).PRT4 and MLPA assays, to completely avoid variations
between plates or batches, analysis was performed in a
plate- or batch- wise manner, so the data sets were too
small to call CNs using the Gaussian mixture model. In
Figure 5 Frequency of samples underestimated by 1 copy by
PRT4 in different CN groups. MLPA CNs were regarded as true.
Absolute numbers are shown above the columns.
Figure 7 PCR products from 4 clones under PRT4 conditions.
RC017T and RC147T indicate 2 clones containing T allele amplicons
from RC017 and RC147. RC017C and RC147C indicate 2 clones
containing C allele amplicons from RC017 and RC147. H2O means a
non-template control.
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centers determined from reference samples and actual
cluster centers determined from the test samples, CNs
called by Gaussian mixture modeling using reference
samples will also be misestimated. In contrast, these mis-
estimations can be avoided by the developed clustering
approach, which furthermore allows setting a threshold of
confidence enhancing the reliability of the determination.
MLPA had the highest call rate of > 99%, which is
higher than that reported in triplex PRT (95%) in which
also a likelihood analysis with a threshold of confidence
was applied [16]. In contrast, the PRT4 applied by us had
a considerably lower call rate (only 82%) especially for
high CNs. It was considered that loss of large amount of
data or/and biased loss of data between cases and controlsFigure 6 Paralogous sequence variation C > T (PSV, chr8:
7277574, rs187261177) in the PRT4 forward primer binding site
(5’-CACTTGTCCCACCAACCTTC). Sequencing traces of two clones
derived from sample RC081 (CN = 5 by MLPA, CN = 4 by PRT4)
represent (A) the major and (B) the minor PSV allele.could generate spurious associations in CNV association
studies [16]. In case of qPCR, the initial low call rate of
84% could be increased by a second run to almost 97%.
Possibly, the call rate of PRT4 could also be increased by
repeating the assay several times, but in contrast to qPCR
it is time and labor consuming.
Accordingly, we found a high concordance rate be-
tween MLPA and PRT4 but a lower one between MLPA
or PRT4 and qPCR. Most of the MLPA and PRT4 CNs
agreed except 22 cases where PRT4 missed exactly one
DEFB copy. We could explain this phenomenon by identi-
fying a PSV in the PRT4 forward primer which completely
abolished amplification from DEFB clusters containing
the minor T allele. Unknown during the assay design and
the course of the work it turned out to be identifiedTable 2 10 samples and genomic DNA pool for variation
screening in primer binding site in PRT4
Sample MLPA CN PRT4 CN Clones sequenced Clones with
variation
RC017 3 2 10 3
RC147 3 2 11 5
RC191 4 3 11 2
RC206 4 3 12 4
RC081 5 4 26 6
RC287 5 4 31 5
RC006 6 5 41 5
RC020 6 5 36 4
RC011 7 6 41 01
RC121 7 6 84 2
Sum 50 40 303 36
Pool n.d. n.d. 65 0
1Number of sequenced clones too low for variation detection with high
power. n.d. means not determined.
Figure 8 DEFB CN distributions from three methods.
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although no minor allele frequency was reported yet.
Missing this PSV among 65 clones from the DNA pool of
80 individual DNA indicates that it is a low-frequency
variation. In respect to the 232 samples with both MLPA
CNs and PRT4 CNs in the present study, comprising
altogether 1003 copies of the DEFB cluster, the minor
PSV allele frequency is 2.2%. Assuming a random distribu-
tion of this PSV allele among DEFB CN alleles (e.g. chro-
mosomes with a particular copy of the DEFB cluster)
would result in linearly increased frequency of samples
underestimated with copy numbers, e.g. the probability to
underestimate a CN by 1 is four times higher for a 8-copy
genome compared to a 2-copy genome. This assumption
is supported by the linear trend between CN and the fre-
quency of samples underestimated we observed (Figure 5)
although the sample size (232 individuals) is small.
Most remarkably, the CN distributions of the three
methods differed significantly. Among them, the distri-
bution from MLPA is very comparable to the recently re-
ported distribution obtained by triplex PRT in European
populations [14,24]. The distribution from qPCR shifted
to low CNs due to underestimation of CNs, whereas a
similar shift for PRT4 is caused by its low call rate at high
CNs and underestimation by one copy in the samples car-
rying the PSV rs187261177 at the primer binding site.
There are several advantages of MLPA over PRT and/or
qPCR in design. The first is given by the usage of several
markers. Ten markers within the DEFB cluster and 25
single-copy reference loci were used to interrogate the CN
in MLPA in contrast to only one marker in qPCR and
PRT4. Different behaviors of different markers inducing
discrepant CN estimations were reported for qPCR [22]
and PRT [16]. Therefore, in our opinion the combination
of numerous markers is a crucial prerequisite to achieve a
comprehensive and accurate estimation of CN by avoiding
bias(es) from single markers. This assumption is sup-
ported by the CN determination with triplex PRT [16,24].In this method, three markers were included and raw data
showed good convergence around the cluster centers.
Moreover, CNs from triplex PRT were consistent with
those from MLPA in a panel of DNA samples (see Table 1
in FODE et al. 2011). Based on this assumption, the PRT4
assay could be combined with other assays, e.g. previously
established PRTs [16,20] to avoid the bias from the PSV
rs187261177 in primer binding site and further improve
the performance for CN determination.
Another advantage of MLPA is evident from the de-
scribed PRT4 CN determination problem due to a PSV at
the primer binding site. MLPA probe targeting sites are
usually located in functional genes which are under strong
negative selection and whose variations are well character-
ized. Furthermore, it was shown that variations at the probe
hybridization site only influence its efficiency if positions
directly adjacent to the ligation site are affected [26]. How-
ever, in PRT4, the pseudogene HSPDP3 is the target and a
PSV in the primer binding site in one copy of the DEFB
clusters resulted in complete PCR dropout of respective
copy and consequent underestimation of CN of samples.
Pseudogenes, especially retrotransposed pseudogenes lack-
ing active promoters, represent putatively unconstrained se-
quences which are accumulating variations due to the lack
of selection pressure [27,28]. SNP density and Ka/Ks ratios
of pseudogenes are significantly higher than those of genes
[29] and, overall, variation in pseudogenes is less well char-
acterized because they are not common targets of rese-
quencing projects as genes are. Accordingly, it is likely that
unknown variations may compromise primer binding sites.
Furthermore, processes like gene conversion and/or non-
allelic homologous recombination between different
pseudogenes of the same family (and with the functional
gene) may further increase the genetic variability within
primer binding sites. In addition, the high annealing tem-
peratures applied to ensure the PCR specificity make the
PRT assays susceptible to the sequence variations in pri-
mer binding sites. The problem in PRT4 is also seen with
the PRT applied for the estimation of DEFB CN [20]. We
identified rs56784821 as being present on one DEFB copy
in the HapMap/CEPH sample NA18502 causing under-
estimation of its CN by one (data not shown) [7]. In
addition, the PSV rs187261177 interfering with our PRT4
assay is also located within the reverse primer binding site
of HSPD21-PRT [16] although at the 5’ end. Therefore, it
is possible that the low call rate in PRT4 is due to add-
itional primer binding site variants in the target locus
and/or its paralogs on other chromosomes. Altogether,
these results suggest that pseudogenes should be avoided
as targets for paralog ratio tests whenever possible.
Conclusions
Although expensive and time consuming, MLPA is su-
perior to qPCR and PRT4 for DEFB CN determination.
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to be applied in association studies and the raw data
should be subjected to cluster analysis using thresholds
of confidence.
Methods
Genomic DNA
A number of 285 healthy blood donors of European an-
cestry were enrolled in this study. This study was ap-
proved by the ethics committee of the Canton Bern,
Switzerland. Written informed consent from all of the
participants was obtained. Genomic DNA was isolated
from peripheral whole blood using QIAamp DNA-blood
Mini Kit (Qiagen, Hilden, Germany) according to manu-
facturer’s instructions. A human genomic DNA pool
(Roche, Mannheim, Germany) containing DNA from 80
healthy individuals was also purchased. In addition, four
DNAs (NA18552, NA15324, NA12760 and NA18858)
with known CN (2, 4, 6 and 8, respectively) were isolated
from commercially available lymphoblastoid cell lines
(Coriell Cell repository http://www.coriell.org/). Reliable
copy number details of these samples are from inde-
pendent, methodologically different determinations from
different laboratories (see Table 2 in Groth et al. 2008
and references therein). The concentration and purity of
DNA were determined by a NanoDrop spectrophotometer
(Thermo Scientific, Wilmington, USA). A260/A280 ≥ 1.7
and A260/A230 ≥ 1.5 were reached in all samples. The
concentration ranged from 50 to 200 ng/μl.
qPCR
qPCR was modified from our previously established
method by targeting DEFB4 [17]. In brief, the target locus
in DEFB4 and the reference locus in the human albumin
gene (ALB) were amplified simultaneously in a duplex
PCR. The primers and probes as well as the PCR condi-
tions were the same as we used in a previously established
method [17]. PCR was performed in duplication for each
sample. Genomic DNAs NA18552 and NA15324 werechr13   CATCACTTGTCTCACCAACCATCAACACGGCTACTCCATCTGAAAGT
chr5    CATCACTTGTTACACCAACCTTCAGCACAGCTACTCCATTTTAAAGT
chr12   CATCACTTGTCCCACCAACCTTCAGCACAGCTACTACATCTGAAAGT
chr3    CATCACTTGTCCCACCAACCTTTGGCATAGCTATCCCATCTGAAAGT
chr5    CATCACTTGTCCCACCAAACTTCAGCACAACTACTCCATCTGAAAGT
chr4    CATCACTTGTCCCACCAACCTTCAGCACAGCTACTCCATCTGAAAGT
chr8    CATCACTTGTCCCACCAAYCTTCAGCACAGCTACTCCATCTGAAAGT
chr21   CGTGACTTGTCCCACTAACCTTCAGCACAGCTACTCCATCTGAAAGT
chr6    CATCACTTGTCCCACCAGCCTTCAGCACTGCTACTCCATCTGAAAGT
chr13   CATCACTTGTCCCACCAACCTTCAGCACAGCTACTCCATCTGAAAAG
chr1    CATCATTTTTCCCATCAACCTTCAGCACAGCTATTGCATCC-AAAAT
Figure 9 PRT4 primer design and locus specificity. Partial sequences of
were designed to amplify loci only on chromosome 8 (target) and chromo
perfect match; yellow: primer binding site with mismatches; purple: misma
products; blue: paralogous sequence variation rs187261177.used as calibrator and positive control, respectively. The
PCR efficiencies for target and reference genes were deter-
mined by amplifying a randomly selected sample in
10-step dilution series. The calibrator and positive control
were included in each PCR run. Gene dosage ratio between
DEFB4 and ALB can be determined by integrating Cp
values (cycle number when the signal reaches the thresh-
old) and PCR efficiencies for two genes. Raw CN was
determined by normalizing the gene dosage ratio of
unknown samples to that of the calibrator. This calcula-
tion was performed by the Lightcycler relative quantifica-
tion software 1.0 (Roche). Raw CN were rounded to the
nearest integer. Only when the positive control showed
the correct CN, the CNs of unknown samples were
deemed to be correct. In addition, only when the dupli-
cated PCRs for unknown sample showed consistent CNs,
the result was accepted. A second run with PCR in dupli-
cation was performed for the samples with inconsistent
CNs in the first run.
PRT
Our PRT (termed as PRT4) was designed on the basis of
the PRT described by Armour et al. [20] targeting
HSPDP3. The paralog in the DEFB cluster on chromo-
some 8 (target locus) and the paralog on chromosome 4
(reference locus) were exclusively amplified by using spe-
cific primers (Figure 9): 5’-CACTTGTCCCACCAACCTT
C-3’ (forward) and 5’-GGTCTTCAGGTTGTGGCAGT-3’
(reverse). The reverse primer was 5’-6-carboxyfluorescein
(FAM)-labeled. PCR was performed as follows: pre-
denaturation at 95°C for 3 minutes, 26 cycles of denatur-
ation at 93°C for 30 seconds followed by annealing and
elongation at 68°C for 1 minute, final elongation at 72°C
for 45 minutes and cooling at 18°C for 2 minutes. Two
independent PCRs separated in two 96-well plates were
performed for each sample. Genomic DNAs NA18552,
NA15324, NA12760 and NA18858 were included as refer-
ence samples in all plates. The PCR products from target
and reference locus can be distinguished by length, so theyTTTGCCAGATATTCATT...TTTGGCTGCTACAACCTGAAGACCAACTTTT 
TTTGCCA----TTCATT...TTTTACTGCTATAACCTGAGGACCAGCTTTT 
TTTGCCAGCCGTTCATT...CTTGATTGCCACATCCTGAAGACCAACCTTT 
TTTGCCAG----TCATT...CTTGACTGCCACAACCTGAAAATCAATCTTT 
TTTGCCAGCCATTCATT...CTTGACTGCCACAACCTGAAGACCAACCTTT 
TTTGCCAGT-GTTCATT...CTTGACTGCCACAACCTGAAGACCAACCTTT 
TTCTCCA--------TT...TTTGACTGCCACAACCTGAAGACCAACCTTT 
TTTGCCAGCTGTTCATT...TTTGACTGCTACAACCTGAAGACCAAGTTTT 
TTTGCCAGACATACATT...TTTGACTGCTATGATCTGAAGACCAACTTTT 
TTTTCCAGCCATTCTAT...TTTGACTGCTATAATGTGAAGACCAACTTTT 
TTTGCCGGATGTTCTTC...TTTGACTACTGTAGCCTGAATACCAATCTTT 
HSPDP3 paralogs on different chromosomes are shown. The primers
some 4 (reference). Gray: amplified loci; green: primer binding site with
tch; red: deletion which generates the length difference of PCR
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labeled PCR products were appropriately diluted (up to
1/40) and 1 μl of the dilution was supplemented with
10 μl formamide (Roth, Karlsruhe, Germany) and 0.5 μl of
GeneScan ROX 500 marker (Applied Biosystems, Darm-
stadt, Germany). The mixture was incubated at 94°C for
3 min, and the denatured PCR products were then sepa-
rated on an ABI 3730 capillary sequencer and analyzed
with the GeneMapper 4.0 software (Applied Biosystems).
The amount of each amplicon within a PCR reaction was
calculated by the respective area under the curve. Subse-
quent calculations of raw CNs are the ratios of areas from
target locus amplicon and reference locus amplicon assum-
ing a CN of two for the reference locus (CN= 2 × target/
reference).
MLPA
MLPA was performed as described [7] using the SALSA
MLPA P139-B1 Defensin kit (MRC Holland, Amsterdam,
The Netherlands). The MLPA probe set consists of 40
probes of which 5 are hybridizing to genes/pseudogenes
within alpha-defensin (DEFA) cluster, 10 to genes within
DEFB cluster and 25 to bona fide single-copy genes on
chromosome 8 as well as on other chromosomes, respect-
ively. In brief, hybridization, ligation, amplification and
electrophoresis were carried out. Peak areas were normal-
ized against the summed peak areas of the “five nearest
neighbor” (5nn) reference probes to obtain 5nn values for
each individual sample, and relative locus doses of DEFB
cluster were calculated by averaging the 5nn values of
the 10 probes targeting DEFB cluster. Genomic DNAs
NA18552, NA15324, NA12760 and NA18858 were in-
cluded as reference samples in all experiements/batches.
DEFB CNs were determined in a batch-wise manner. Each
batch included reference samples as described and a num-
ber of 30–50 unknown samples. One measurement was
performed for each test sample.
Cluster analysis
To infer integer CN from experimental values (raw CNs
of PRT4 and relative locus doses of MLPA), a cluster al-
gorithm was developed. The details of this algorithm are
introduced as follows. Firstly, the values of the reference
samples with even CNs were determined experimentally.
The values of reference samples with odd CNs were in-
terpolated by a linear regression. Those reference values
were used as primary cluster means. Then the values of
unknown samples in each 96-well plate (PRT4) or batch
(MLPA) were clustered to the closest primary cluster
means. The new cluster means were calculated after
clustering. Furthermore, the second closest cluster mean
for each value was identified to determine the likelihood
for its assignment. This likelihood is expressed as fol-
lows: square of the distance to the second closest clustermean/(square of the distance to the closest cluster
mean + square of the distance to the second closest clus-
ter mean). This formula implies that the more similar
the distances of a value to its closest and second closest
cluster mean are, the lower is the likelihood to deter-
mine the true value. The minimal threshold of the likeli-
hood was set to 0.6 for both PRT4 and MLPA. In PRT4,
only when the CNs from two independent PCRs were
consistent, the CN was deemed to be reliable. This clus-
tering algorithm was run under R (http://www.r-project.
org/) on a UNIX platform. The program can be down-
loaded from http://genome.fli-leibniz.de/software.
Mutation screening in primer binding site in PRT4
To inspect primer binding sites in the DNA pool
(Roche) and DNA samples with CNs consistently differ-
ing by one between PRT4 and MLPA, PCR was carried
out with primers outside of PRT4 targeted regions: 5’-
CAATGCCTTCTTCAACAGCA-3’ (forward) and 5’-
AATGTGAATTCCAGGATGCC-3’ (reverse). PCR was
performed using 50 ng of template DNA. PCR condi-
tions were as follows: pre-denaturation at 95°C for 1 mi-
nute, 30 cycles of denaturation at 95°C for 30 seconds
followed by annealing at 59°C for 30 seconds and elong-
ation at 72°C for 1 minute, final elongation at 72°C for
30 minutes and cooling at 18°C for 1 minute. PCR products
were precipitated with ammonium acetate and ethanol,
dried and re-dissolved in water. For primers amplifying sev-
eral HSPDP3 paralogs direct amplicon sequencing was
not feasible. Accordingly, the amplicon was cloned into
pCR2.1 vector with the TOPO TA Cloning Kit (Invitrogen,
Darmstadt, Germany) according to the manufacturer's
instructions. Well isolated white colonies were picked and
grown in LB Broth supplemented with ampicillin. Plasmid
DNA was isolated from the cultures by automated
BioRobot 8000 (Qiagen) and inserts were sequenced
in both directions using M13 universal primers. PRT4
target amplicons were identified by their sequences and
visualized/analyzed using Genome Assembly Program
(GAP) [30]. About two-thirds of all clones derived from
chromosome 8 and could be evaluated, and the main con-
taminations are from pseudogene copies from chromo-
somes 6, 12 and 16.
Statistical analysis
Statistical analyses and plotting were performed using
GraphPad Prism 5.01 for Windows (GraphPad Software,
San Diego, CA). The call rates (the samples with deter-
mined CNs/all the samples) of three methods were com-
pared using Chi-square test. A comparison of likelihood
values in clustering analysis of PRT4 and MLPA was
performed using Mann–Whitney test. The inter-method
concordance rates (the samples with consistent CNs be-
tween two methods/the samples with CNs determined
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and the inter-method differences were visually analyzed
by Bland-Altman plots. Comparisons of CN from three
methods were performed using Kruskal-Wallis test with
post-hoc Dunn’s test. All the statistical tests were two-
tailed, and P values < 0.05 were considered as statistically
significant.
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